IDSA on X: New in CID: A #dengue vaccine candidate was efficacious against symptomatic dengue in children and adolescents over 3 years post-vaccination across 8 endemic countries. 📄: #IDSAJournals #ClinInfectDis
Por um escritor misterioso
Descrição
Genetic epidemiology of dengue viruses in phase III trials of the
Resources, Dengue
Host immunity and vaccine development against Dengue virus
Frontiers Anti-dengue Vaccines: From Development to Clinical Trials
Incidence of invasive pneumococcal disease in children with
Invasive Pneumococcal Disease in Children 5 Years After Conjugate
Current Status of Vaccines against Dengue Virus
Dengue Vaccine - an overview
Four-year safety follow-up of the tetravalent dengue vaccine
Opportunities for improved surveillance and control of dengue from
Dengue and Zika virus infections are enhanced by live attenuated
Dengue Vaccines: An Update
Impact of preexisting dengue immunity on Zika virus emergence in a
Incidence of invasive pneumococcal disease in children with
IDSA GUIDELINES Bundle (free trial) - Vaccination of the
